Keat Lam Ho
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Keat Lam Ho has a total of 7 co-authors. Here are the top co-authors by number of shared publications:
- Phaik Har Yong
School of Bioscience, Faculty of Medicine, Bioscience and Nursing, MAHSA University, Selangor, Malaysia
2 shared publications - Zhi Xiang Ng
School of Biological and Environmental Sciences, Faculty of Science and Engineering, University of Nottingham Malaysia, Semenyih, Malaysia
2 shared publications Chee Woon Wang
Department of Biochemistry, Faculty of Medicine, Bioscience and Nursing, MAHSA University, 42610 Selangor, Malaysia
1 shared publicationChek Tung Ngo
Optimax Sunway Eye Specialist Centre, Bandar Sunway, 46150 Selangor, Malaysia
1 shared publication- Festo Massawe
School of Biosciences, University of Nottingham Malaysia, Semenyih, Selangor, Malaysia
1 shared publication - Siew-Huah Lim
Department of Chemistry, Faculty of Science, Universiti Malaya, 50603 Kuala Lumpur, Malaysia
1 shared publication
Latest Publications
- 22 July 2024
- Published by Wiley in Archiv der Pharmazie
- Vol. 357 (10) , e2400299
Peperomia pellucida (L.) Kunth suppresses glycation‐induced inflammatory response in human retinal pigment epithelial cell line ARPE‐19 via JAK‐STAT3 signaling
The formation of advanced glycation end product (AGE) is a risk factor for diabetic retinopathy. Since the current treatment for diabetic retinopathy is accompanied by side effects, preliminary findings have suggested Peperomia pellucida (L.) Kunth as a potential alternative therapeutic option for diabetic retinopathy. This study aimed to elucidate the anti‐inflammatory mechanism of P. pellucida in the AGE‐stimulated human retinal pigment epithelial cell line ARPE‐19. Phytochemical analysis revealed phenylpronanoids, terpenes, and fatty acids in P. pellucida. Through in vitro cell viability assay, the P. pellucida methanolic extract (IC50 = 8.70 mg/mL) and ethyl acetate fraction (IC50 = 7.34 mg/mL) were considered as non toxic for ARPE‐19. AGE induced an inflammatory response in ARPE‐19 by upregulating the gene (2.4–5.8‐fold) and protein (1.4–2.3‐fold) expression of signal transducer and activator of transcription 3 (STAT3), interleukin‐8 (IL‐8), monocyte chemoattractant protein‐1, matrix metalloproteinase 2, and vascular endothelial growth factor. At 1.5 mg/mL, P. pellucida methanolic extract suppressed IL‐8 expression (p < 0.05), implying its anti‐inflammatory action at the early inflammatory stage through the Janus kinase (JAK)‐STAT3 pathway. The methanolic extract also restored the ARPE‐19 viability under AGE‐induced inflammatory stress. The downregulation of inflammatory biomarkers along the JAK‐STAT3 pathway suggested P. pellucida as a promising anti‐inflammatory source for diabetic retinopathy.
- 22 July 2024
- Published by Wiley in Archiv der Pharmazie
- Vol. 357 (10) , e2400299
Peperomia pellucida (L.) Kunth suppresses glycation‐induced inflammatory response in human retinal pigment epithelial cell line ARPE‐19 via JAK‐STAT3 signaling
The formation of advanced glycation end product (AGE) is a risk factor for diabetic retinopathy. Since the current treatment for diabetic retinopathy is accompanied by side effects, preliminary findings have suggested Peperomia pellucida (L.) Kunth as a potential alternative therapeutic option for diabetic retinopathy. This study aimed to elucidate the anti‐inflammatory mechanism of P. pellucida in the AGE‐stimulated human retinal pigment epithelial cell line ARPE‐19. Phytochemical analysis revealed phenylpronanoids, terpenes, and fatty acids in P. pellucida. Through in vitro cell viability assay, the P. pellucida methanolic extract (IC50 = 8.70 mg/mL) and ethyl acetate fraction (IC50 = 7.34 mg/mL) were considered as non toxic for ARPE‐19. AGE induced an inflammatory response in ARPE‐19 by upregulating the gene (2.4–5.8‐fold) and protein (1.4–2.3‐fold) expression of signal transducer and activator of transcription 3 (STAT3), interleukin‐8 (IL‐8), monocyte chemoattractant protein‐1, matrix metalloproteinase 2, and vascular endothelial growth factor. At 1.5 mg/mL, P. pellucida methanolic extract suppressed IL‐8 expression (p < 0.05), implying its anti‐inflammatory action at the early inflammatory stage through the Janus kinase (JAK)‐STAT3 pathway. The methanolic extract also restored the ARPE‐19 viability under AGE‐induced inflammatory stress. The downregulation of inflammatory biomarkers along the JAK‐STAT3 pathway suggested P. pellucida as a promising anti‐inflammatory source for diabetic retinopathy.
- 2 February 2022
- Published by Elsevier in Journal of Integrative Medicine
- Vol. 20 (4) , 292-304
Peperomia pellucida (L.) Kunth and eye diseases: A review on phytochemistry, pharmacology and toxicology
- 2 February 2022
- Published by Elsevier in Journal of Integrative Medicine
- Vol. 20 (4) , 292-304
Peperomia pellucida (L.) Kunth and eye diseases: A review on phytochemistry, pharmacology and toxicology